543271 Stock Overview
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Jubilant Ingrevia Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹534.50 |
| 52 Week High | ₹581.75 |
| 52 Week Low | ₹379.20 |
| Beta | 0.30 |
| 1 Month Change | 8.28% |
| 3 Month Change | 22.62% |
| 1 Year Change | 24.32% |
| 3 Year Change | 27.19% |
| 5 Year Change | n/a |
| Change since IPO | 97.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543271 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -1.4% | -0.3% | -0.8% |
| 1Y | 24.3% | 18.1% | 42.5% |
Return vs Industry: 543271 exceeded the Indian Chemicals industry which returned 18.3% over the past year.
Return vs Market: 543271 underperformed the Indian Market which returned 44.7% over the past year.
Price Volatility
| 543271 volatility | |
|---|---|
| 543271 Average Weekly Movement | 6.5% |
| Chemicals Industry Average Movement | 6.4% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 9.9% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 543271 has not had significant price volatility in the past 3 months.
Volatility Over Time: 543271's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 2,295 | Chandan Sengar | jubilantingrevia.com |
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical intermediates. The Specialty Chemicals segment offers pyridine and picolines, fine chemicals, crop protection chemicals, and custom development and manufacturing services.
Jubilant Ingrevia Limited Fundamentals Summary
| 543271 fundamental statistics | |
|---|---|
| Market cap | ₹85.16b |
| Earnings (TTM) | ₹2.06b |
| Revenue (TTM) | ₹42.06b |
41.4x
P/E Ratio2.0x
P/S RatioIs 543271 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543271 income statement (TTM) | |
|---|---|
| Revenue | ₹42.06b |
| Cost of Revenue | ₹20.57b |
| Gross Profit | ₹21.50b |
| Other Expenses | ₹19.44b |
| Earnings | ₹2.06b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 12.93 |
| Gross Margin | 51.10% |
| Net Profit Margin | 4.90% |
| Debt/Equity Ratio | 28.3% |
How did 543271 perform over the long term?
See historical performance and comparison